Boon Cher Goh

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3K citations · Full text

Neoadjuvant Therapy, Chemotherapy Versus Cetuximab, Medicine +7

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

Wan‐Teck Lim, Boon Cher Goh, Edwin P. Hui et al. · Journal of Clinical Oncology · 2018 · 455 citations · Full text

Metastatic Npc, Oncology, Antitumor Activity +15

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study

Keith C. Bible, Vera J. Suman, Julian R. Molina et al. · The Lancet Oncology · 2010 · 414 citations · Full text

Thyroid Cancers, Oncology, Medicine +11

The genomic landscape of nasopharyngeal carcinoma

De‐Chen Lin, Xuan Meng, Masaharu Hazawa et al. · Nature Genetics · 2014 · 370 citations

Tumor Heterogeneity, Genomic Landscape, Nasopharyngeal Cancer +5

Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Anthony T.�C. Chan, Mow-Ming Hsu, Boon Cher Goh et al. · Journal of Clinical Oncology · 2005 · 289 citations · Full text